PTH and progressive osseous heteroplasia: The evidence collected over the last decade outlined the limits of the rigid historical classification and a recent proposal suggests to rename an heterogenous but highly overlapping group of diseases encompassing PHP, PPHP, POH and acrodysostosis under the term “inactivating PTH/PTHrP signaling disorders (iPPSDs).